Short Interest in Merck KGaA (OTCMKTS:MKKGY) Decreases By 88.9%

Merck KGaA (OTCMKTS:MKKGY) saw a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 900 shares, a decline of 88.9% from the February 28th total of 8,100 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 129,800 shares, the days-to-cover ratio is currently 0.0 days.

Merck KGaA Trading Up 1.9 %

MKKGY stock traded up $0.52 during trading on Friday, reaching $27.75. The company had a trading volume of 157,554 shares, compared to its average volume of 127,004. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.33 and a quick ratio of 0.91. Merck KGaA has a 52 week low of $27.19 and a 52 week high of $39.17. The business has a 50 day moving average of $29.15 and a 200 day moving average of $31.05. The company has a market cap of $17.93 billion, a P/E ratio of 17.13, a PEG ratio of 2.05 and a beta of 0.98.

Merck KGaA (OTCMKTS:MKKGY) last announced its earnings results on Thursday, March 6th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.07. Merck KGaA had a return on equity of 10.41% and a net margin of 12.89%. The firm had revenue of $5.78 billion during the quarter, compared to analyst estimates of $5.40 billion. As a group, sell-side analysts forecast that Merck KGaA will post 1.87 earnings per share for the current fiscal year.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.